Expression of cyclin-dependent kinase inhibitors in vascular disease

Felix C. Tanner, Zhi Yong Yang, Eric Duckers, David Gordon, Gary J. Nabel, Elizabeth G. Nabel

Research output: Contribution to journalArticlepeer-review

Abstract

Arterial lesions in cardiovascular diseases are characterized by proliferation and migration of smooth muscle cells as well as deposition of connective tissue matrix. Factors that stimulate vascular smooth muscle cell (VSMC) proliferation are well described; however, the role of proteins that limit intimal hyperplasia is not well understood. To examine the function of Kip/Cip and INK cyclin-dependent kinase inhibitors (CKIs) in vascular diseases, the expression of p27(Kip1) and p16(INK) was examined in VSMCs in vitro and in porcine arteries and human atherosclerosis in vivo. Western blot and fluorescence activated cell-sorting analysis demonstrated that levels of p27(Kip1), but not p16(INK), increased during serum deprivation of primary VSMC cultures and caused G1 arrest. p27(Kip1) inhibited Cdk2 activity, suggesting that Kip CKIs promote G1 arrest in VSMCs by binding cyclin E/Cdk2. In porcine arteries, p27(Kip1), but not p16(INK), was constitutively expressed at low levels. Immediately after balloon injury, cell proliferation increased as p27(Kip1) levels declined. Three weeks after injury, p27(Kip1) was strongly expressed in intimal VSMCs when VSMC proliferation was 1 phase of the cell cycle.

Original languageEnglish (US)
Pages (from-to)396-403
Number of pages8
JournalCirculation Research
Volume82
Issue number3
StatePublished - Feb 23 1998
Externally publishedYes

Keywords

  • Cell cycle
  • Cyclin-dependent kinase
  • Vascular smooth muscle cell

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Expression of cyclin-dependent kinase inhibitors in vascular disease'. Together they form a unique fingerprint.

Cite this